Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Post-Lung Transplant Airway Complications
NCT02363959Phase 2Completed
- Sponsor
- Duke University
- Start
- Feb 2015
- Primary completion
- Sep 2018
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxygen in central airway stenosis (CAS) (2 arms), sponsored by Duke University. Primary endpoints: Subjects Needing Airway Stent Placement as Determined by Transbronchial Lung Biopsy at 12 months and Number of Subjects Experiencing Acute Cellular Rejection as Determined by Transbronchial Lung Biopsy at 12 months. Started Feb 2015; status: completed.
02
Drugs
oxygen
03
Conditions
central airway stenosis (CAS)
Beyond the preview
Go deeper on NCT02363959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363959.